Below are the most recent publications written about "Disease" by people in Profiles.
-
Putman TE, Schaper K, Matentzoglu N, Rubinetti VP, Alquaddoomi FS, Cox C, Caufield JH, Elsarboukh G, Gehrke S, Hegde H, Reese JT, Braun I, Bruskiewich RM, Cappelletti L, Carbon S, Caron AR, Chan LE, Chute CG, Cortes KG, De Souza V, Fontana T, Harris NL, Hartley EL, Hurwitz E, Jacobsen JOB, Krishnamurthy M, Laraway BJ, McLaughlin JA, McMurry JA, Moxon SAT, Mullen KR, O'Neil ST, Shefchek KA, Stefancsik R, Toro S, Vasilevsky NA, Walls RL, Whetzel PL, Osumi-Sutherland D, Smedley D, Robinson PN, Mungall CJ, Haendel MA, Munoz-Torres MC. The Monarch Initiative in 2024: an analytic platform integrating phenotypes, genes?and diseases across species. Nucleic Acids Res. 2024 Jan 05; 52(D1):D938-D949.
-
Shao Y, Zhang QC. Targeting RNA structures in diseases with small molecules. Essays Biochem. 2020 12 07; 64(6):955-966.
-
Javadov S, Kozlov AV, Camara AKS. Mitochondria in Health and Diseases. Cells. 2020 05 09; 9(5).
-
Deng Y, Wang H, Hamamoto R, Duan S, Pirooznia M, Bai Y. Functional Genomics, Genetics, and Bioinformatics 2016. Biomed Res Int. 2016; 2016:2625831.
-
Levine RS, Kilbourne BA, Rust GS, Langston MA, Husaini BA, Gittner LS, Sanderson M, Hennekens CH. Social determinants and the classification of disease: descriptive epidemiology of selected socially mediated disease constellations. PLoS One. 2014; 9(11):e110271.
-
Mihaljevic JR, Joseph MB, Orlofske SA, Paull SH. The scaling of host density with richness affects the direction, shape, and detectability of diversity-disease relationships. PLoS One. 2014; 9(5):e97812.
-
Mandal PK, Soni S, Reams RR, Verri T, Mandal A, Mishra S. Molecular biomarkers: tools of medicine. Biomed Res Int. 2013; 2013:595496.
-
Sulakhe D, Balasubramanian S, Xie B, Feng B, Taylor A, Wang S, Berrocal E, Dave U, Xu J, B?rnigen D, Gilliam TC, Maltsev N. Lynx: a database and knowledge extraction engine for integrative medicine. Nucleic Acids Res. 2014 Jan; 42(Database issue):D1007-12.
-
Miklossy G, Hilliard TS, Turkson J. Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov. 2013 Aug; 12(8):611-29.
-
Lindblad-Toh K, Garber M, Zuk O, Lin MF, Parker BJ, Washietl S, Kheradpour P, Ernst J, Jordan G, Mauceli E, Ward LD, Lowe CB, Holloway AK, Clamp M, Gnerre S, Alf?ldi J, Beal K, Chang J, Clawson H, Cuff J, Di Palma F, Fitzgerald S, Flicek P, Guttman M, Hubisz MJ, Jaffe DB, Jungreis I, Kent WJ, Kostka D, Lara M, Martins AL, Massingham T, Moltke I, Raney BJ, Rasmussen MD, Robinson J, Stark A, Vilella AJ, Wen J, Xie X, Zody MC, Baldwin J, Bloom T, Chin CW, Heiman D, Nicol R, Nusbaum C, Young S, Wilkinson J, Worley KC, Kovar CL, Muzny DM, Gibbs RA, Cree A, Dihn HH, Fowler G, Jhangiani S, Joshi V, Lee S, Lewis LR, Nazareth LV, Okwuonu G, Santibanez J, Warren WC, Mardis ER, Weinstock GM, Wilson RK, Delehaunty K, Dooling D, Fronik C, Fulton L, Fulton B, Graves T, Minx P, Sodergren E, Birney E, Margulies EH, Herrero J, Green ED, Haussler D, Siepel A, Goldman N, Pollard KS, Pedersen JS, Lander ES, Kellis M. A high-resolution map of human evolutionary constraint using 29 mammals. Nature. 2011 Oct 12; 478(7370):476-82.